Table 4

Diagnostic accuracy of pairs of cut-offs from the literature for liver stiffness measurement (LSM) by vibration controlled transient elastography (VCTE), Fibrosis-4 Index (FIB-4) and NAFLD (non-alcoholic fatty liver disease) Fibrosis Score (NFS) for diagnosing advanced fibrosis

LSM by VCTE
(n=5489)
FIB-4
(n=5393)
NFS
(n=3248)
Advanced fibrosis, %303029
AUROC0.85 (0.84–0.86)0.76 (0.74–0.77)0.73 (0.71–0.75)
SourceAnstee et al 29 Eddowes et al 31 Wong et al 76 Wong et al 20 This studyShah et al 83 McPherson et al 84 This studyAngulo et al 16 This study
Thresholds<9.9, ≥11.4<7.1, ≥14.1<10, ≥15<7.9, ≥9.6<7.4, ≥12.1*<1.3, ≥2.67<1.3, ≥3.25<0.88, ≥2.31*<−1.455, ≥0.676<−2.55, ≥0.28*
Sensitivity, %69 (67–71)83 (80–86)59 (57–61)84 (82–87)84 (81–87)54 (52–56)44 (42–46)80 (76–83)47 (44–50)74 (70–79)
Specificity, %86 (85–88)90 (88–92)94 (93–96)78 (76–80)87 (85–88)91 (89–92)95 (93–96)79 (77–81)91 (89–93)78 (76–81)
Misclassified, %17 (16–19)7 (6–8)12 (11–13)17 (16–19)10 (9–11)12 (11–13)10 (9–11)10 (9–11)11 (10–13)10 (8–11)
Indeterminate, %7 (6–8)39 (37–40)18 (17–19)13 (12–14)31 30–33)34 (33–35)39 (37–40)52 (50–53)39 (37–41)56 (54–59)
  • *Cut-offs determined from the individual patient data study group. Lower cut-offs correspond to a lower limit of 90% sensitivity, upper cut-offs correspond to a lower limit of 90% specificity. 95% CIs were determined with 500 bootstrap replicates.

  • AUROC, area under the receiver operating characteristic.